NCT00309270View on ClinicalTrials.gov

Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

April 30, 2010

Conditions

Kidney Transplant

Interventions

DRUG

Campath-1H

Trial Locations (1)

24128

"Hospital Ospedali Riuniti of Bergamo", Bergamo

All Listed Sponsors

lead

Mario Negri Institute for Pharmacological Research

OTHER

NCT00309270 - Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation | Biotech Hunter | Biotech Hunter